Lord, Abbett & Co. LLC Trans Medics Group, Inc. Transaction History

Lord, Abbett & Co. LLC

  • $30.7 Billion
  • Q3 2024

A detailed history of Lord, Abbett & Co. LLC transactions in Trans Medics Group, Inc. stock. As of the latest transaction made, Lord, Abbett & Co. LLC holds 809,135 shares of TMDX stock, worth $55.8 Million. This represents 0.41% of its overall portfolio holdings.

Number of Shares
809,135
Previous 533,876 51.56%
Holding current value
$55.8 Million
Previous $80.4 Million 57.98%
% of portfolio
0.41%
Previous 0.26%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$135.68 - $176.11 $37.3 Million - $48.5 Million
275,259 Added 51.56%
809,135 $127 Million
Q2 2024

Oct 07, 2024
BUY
$72.62 - $150.62 $16.6 Million - $34.4 Million
228,457 Added 74.8%
533,876 $80.4 Million
Q2 2024

Aug 14, 2024
BUY
$72.62 - $150.62 $16.6 Million - $34.4 Million
228,457 Added 74.8%
533,876 $80.4 Million
Q1 2024

Oct 07, 2024
SELL
$70.86 - $89.93 $51 Million - $64.8 Million
-720,145 Reduced 70.22%
305,419 $22.6 Million
Q1 2024

May 09, 2024
SELL
$70.86 - $89.93 $51 Million - $64.8 Million
-720,145 Reduced 70.22%
305,419 $22.6 Million
Q4 2023

Oct 07, 2024
BUY
$36.74 - $81.08 $12.9 Million - $28.6 Million
352,470 Added 52.37%
1,025,564 $80.9 Million
Q4 2023

Feb 12, 2024
BUY
$36.74 - $81.08 $12.9 Million - $28.6 Million
352,470 Added 52.37%
1,025,564 $80.9 Million
Q3 2023

Oct 07, 2024
SELL
$53.47 - $96.07 $64 Million - $115 Million
-1,196,645 Reduced 64.0%
673,094 $36.9 Million
Q3 2023

Nov 13, 2023
SELL
$53.47 - $96.07 $64 Million - $115 Million
-1,196,645 Reduced 64.0%
673,094 $36.9 Million
Q2 2023

Oct 07, 2024
BUY
$66.23 - $88.73 $1.04 Million - $1.39 Million
15,656 Added 0.84%
1,869,739 $157 Million
Q2 2023

Aug 14, 2023
BUY
$66.23 - $88.73 $1.04 Million - $1.39 Million
15,656 Added 0.84%
1,869,739 $157 Million
Q1 2023

Oct 07, 2024
BUY
$53.63 - $82.33 $35.7 Million - $54.9 Million
666,277 Added 56.09%
1,854,083 $140 Million
Q1 2023

May 12, 2023
BUY
$53.63 - $82.33 $35.7 Million - $54.9 Million
666,277 Added 56.09%
1,854,083 $140 Million
Q4 2022

Oct 07, 2024
BUY
$39.08 - $64.29 $25.6 Million - $42 Million
653,930 Added 122.49%
1,187,806 $73.3 Million
Q4 2022

Feb 10, 2023
BUY
$39.08 - $64.29 $16.2 Million - $26.7 Million
415,733 Added 53.85%
1,187,806 $73.3 Million
Q3 2022

Nov 14, 2022
BUY
$31.56 - $55.75 $24.4 Million - $43 Million
772,073 New
772,073 $32.2 Million

Others Institutions Holding TMDX

# of Institutions
398
Shares Held
31.9M
Call Options Held
466K
Put Options Held
286K
View Full List

About TransMedics Group, Inc.

TMDX Quotes by TradingView
  • Ticker TMDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 31,831,400
  • Market Cap $2.2B
  • Description
  • TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and custo...
More about TMDX
Track This Portfolio

Track Lord, Abbett & Co. LLC Portfolio

Follow Lord, Abbett & Co. LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lord, Abbett & Co. LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lord, Abbett & Co. LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email